Results 301 to 310 of about 453,156 (401)
Stiripentol use in Dravet syndrome patients in the USA: Results of a real‐world study
Abstract Objective Dravet syndrome (DS) is a severe developmental and epileptic encephalopathy with a high seizure burden and mortality risk. Stiripentol, one of the first DS‐specific therapies, received FDA approval in 2018 but its real‐world use and impact post‐approval in the USA remain insufficiently characterized.
Elaine Wirrell +11 more
wiley +1 more source
Impact of Hypoxic-Ischemic Encephalopathy on Visual Outcomes and Brain MRI Findings in Pediatric Patients: A Retrospective Observational Study From Northeast India. [PDF]
Magdalene D +4 more
europepmc +1 more source
Lentiform Fork Sign Secondary To Metformin-Induced Encephalopathy [PDF]
Michael A. Santos
openalex +1 more source
Abstract Objective Variants in KCNQ2 encoding the voltage‐gated potassium channel KV7.2 are associated with developmental and epileptic encephalopathy (DEE) of varying severity. This study examined the relationship of KCNQ2 variant dysfunction with the neurodevelopmental phenotype of individuals with KCNQ2‐DEE. Methods A parent‐reported survey gathered
Jessa S. Bidwell +4 more
wiley +1 more source
Wernicke's encephalopathy after emergency cholecystectomy and hepatic arterial embolization: A radiological and critical care challenge. [PDF]
Montatore M +4 more
europepmc +1 more source
Abstract Objectives Infantile epileptic spasms syndrome (IESS) is a developmental and epileptic encephalopathy of infantile onset. While epidemiological data from Western countries and global estimates are available, consolidated evidence on the burden of IESS in India remains limited.
Akanksha Singh +6 more
wiley +1 more source
Hypertensive brainstem encephalopathy with isolated headache and blurred vision: A case report. [PDF]
Choi SY, Choi JH, Choi KD.
europepmc +1 more source
Abstract Objective Dravet syndrome (DS) is a rare disease with a high clinical and socioeconomic impact on patients, society, and the healthcare system. The recent approval of therapies such as fenfluramine (FFA) has transformed the treatment landscape; however, data on their cost‐effectiveness are still scarce. This study evaluates the real‐world cost‐
Paolo A. Cortesi +15 more
wiley +1 more source
Clinical characteristics, risk factors, and prognostic modeling for poor outcomes in children with influenza-associated encephalopathy: A retrospective cohort study. [PDF]
Xiao F +6 more
europepmc +1 more source

